Cited by 41

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Novel PET Imaging Probe for Quantitative Detection of Senescence In Vivo

Xiang, Xin, Dong, Chuning, Zhou, Lianbo, Liu, Jun, Rabinowitz, Zachary M., Zhang, Yuzhao, Guo, Honghui, He, Feng, Chen, Xingdou, Wang, Yunhua, Cui, Lina, Ma, Xiaowei·2024·Journal of Medicinal Chemistry

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.4c00179

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Optimized reaction route to [68Ga]Ga-BGal.
Figure 1 Optimized reaction route to [68Ga]Ga-BGal.CC BY-NC-ND · PubMed Central
Figure 2 Radio-HPLC analysis of [68Ga]Ga-BGal. Top, HPLC analysis of the probe before purification; middle, analysis of the probe after 4 h in serum; bottom, analysis of the probe after purification. The labeling yield was 90.0 ± 4.3%. The radiochemical purity was greater than 95%. The stability of the probe in serum for 4 h was above 95%.
Figure 2 Radio-HPLC analysis of [68Ga]Ga-BGal. Top, HPLC analysis of the probe before purification; middle, analysis of the probe after 4 h in serum; bottom, analysis of the probe after purification. The labeling yield was 90.0 ± 4.3%. The radiochemical purity was greater than 95%. The stability of the probe in serum for 4 h was above 95%.CC BY-NC-ND · PubMed Central
Figure 3 PET images of [68Ga]Ga-BGal incubated with (a) β-Gal, inactive β-Gal, BSA, and PBS, (b) β-Gal for 1, 5, 15, 30, and 60 min, and (c) β-Gal for 0.01, 0.015, 0.022, 0.033, and 0.05 μg/μL and the corresponding quantitative analysis. (Percentage: the band accounts for the entire lane.)
Figure 3 PET images of [68Ga]Ga-BGal incubated with (a) β-Gal, inactive β-Gal, BSA, and PBS, (b) β-Gal for 1, 5, 15, 30, and 60 min, and (c) β-Gal for 0.01, 0.015, 0.022, 0.033, and 0.05 μg/μL and the corresponding quantitative analysis. (Percentage: the band accounts for the entire lane.)CC BY-NC-ND · PubMed Central
Figure 4 PET images of [68Ga]Ga-BGal incubated with (a) the protein extracted from CT26.CL25 and CT26.WT cells, (b) CT26.CL25 for 1, 15, 30, 60, and 120 min, and (c) the protein of CT26.CL25 for 0.009, 0.0375, 0.15, 0.6, and 2.4 μg/μL and the corresponding quantitative analysis. (Percentage: the band accounts for the entire lane.)
Figure 4 PET images of [68Ga]Ga-BGal incubated with (a) the protein extracted from CT26.CL25 and CT26.WT cells, (b) CT26.CL25 for 1, 15, 30, 60, and 120 min, and (c) the protein of CT26.CL25 for 0.009, 0.0375, 0.15, 0.6, and 2.4 μg/μL and the corresponding quantitative analysis. (Percentage: the band accounts for the entire lane.)CC BY-NC-ND · PubMed Central
Figure 5 Binding modes of [68Ga]Ga-BGal with (a) E. coli β-Gal and (b) human β-Gal.
Figure 5 Binding modes of [68Ga]Ga-BGal with (a) E. coli β-Gal and (b) human β-Gal.CC BY-NC-ND · PubMed Central
Figure 6 Uptake of [68Ga]Ga-BGal in CT26.CL25, CT26.WT, saline-treated HeLa, and DOX-treated HeLa cells. (a) Dynamic uptake of the probe in CT26.CL25 and CT26.WT cells with or without β-Gal at 0.5, 1, 2, and 4 h. (b) Dynamic uptake of the probe in saline-treated HeLa and DOX-treated HeLa cells at 0.5, 1, 2, and 4 h. (c) Quantitative analysis of the probe in CT26.CL25, CT26.WT, saline-treated HeLa, and DOX-treated HeLa cells at 4 h incubation. (d) Uptake of the probe in CT26.CL25 and CT26.WT with different quantities (0.125, 0.25, 0.5, and 1 μg) of β-Gal after 4 h of incubation (*p < 0.05, **p < 0.01, ***p < 0.001).
Figure 6 Uptake of [68Ga]Ga-BGal in CT26.CL25, CT26.WT, saline-treated HeLa, and DOX-treated HeLa cells. (a) Dynamic uptake of the probe in CT26.CL25 and CT26.WT cells with or without β-Gal at 0.5, 1, 2, and 4 h. (b) Dynamic uptake of the probe in saline-treated HeLa and DOX-treated HeLa cells at 0.5, 1, 2, and 4 h. (c) Quantitative analysis of the probe in CT26.CL25, CT26.WT, saline-treated HeLa, and DOX-treated HeLa cells at 4 h incubation. (d) Uptake of the probe in CT26.CL25 and CT26.WT with different quantities (0.125, 0.25, 0.5, and 1 μg) of β-Gal after 4 h of incubation (*p < 0.05, **p < 0.01, ***p < 0.001).CC BY-NC-ND · PubMed Central
Figure 7 (a, b) Representative PET images obtained at 10 min, 30 min, 1, 2, and 4 h after injection of [68Ga]Ga-BGal in (a) CT26.WT and (b) CT26.CL25 tumor-bearing mice (the red circle represents the tumors). (c) Quantitative analysis of the probe in the heart, liver, kidneys, tumor, muscle, and tumor/muscle ratio from (a, b). (d) Biodistribution of the probe in CT26.WT and CT26.CL25 tumor-bearing mice at 4 h after injection and analysis of the tumor-to-muscle ratio (**p < 0.01, ***p < 0.001).
Figure 7 (a, b) Representative PET images obtained at 10 min, 30 min, 1, 2, and 4 h after injection of [68Ga]Ga-BGal in (a) CT26.WT and (b) CT26.CL25 tumor-bearing mice (the red circle represents the tumors). (c) Quantitative analysis of the probe in the heart, liver, kidneys, tumor, muscle, and tumor/muscle ratio from (a, b). (d) Biodistribution of the probe in CT26.WT and CT26.CL25 tumor-bearing mice at 4 h after injection and analysis of the tumor-to-muscle ratio (**p < 0.01, ***p < 0.001).CC BY-NC-ND · PubMed Central
Figure 8 (a, b) Representative PET images obtained at 10 min, 30 min, 1, 2, and 4 h after injection of [68Ga]Ga-BGal in (a) saline-treated HeLa and (b) DOX-treated HeLa tumor-bearing mice (the red circle represents the tumors). (c) Quantitative analysis of the probe in the heart, liver, kidneys, tumor, muscle, and tumor/muscle ratio from (a, b). (d) Biodistribution of the probe in saline-treated HeLa and DOX-treated HeLa tumor-bearing mice at 4 h after injection and analysis of the tumor-to-muscle ratio (*p < 0.05, **p < 0.01).
Figure 8 (a, b) Representative PET images obtained at 10 min, 30 min, 1, 2, and 4 h after injection of [68Ga]Ga-BGal in (a) saline-treated HeLa and (b) DOX-treated HeLa tumor-bearing mice (the red circle represents the tumors). (c) Quantitative analysis of the probe in the heart, liver, kidneys, tumor, muscle, and tumor/muscle ratio from (a, b). (d) Biodistribution of the probe in saline-treated HeLa and DOX-treated HeLa tumor-bearing mice at 4 h after injection and analysis of the tumor-to-muscle ratio (*p < 0.05, **p < 0.01).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 36

  1. 10.1038/s41581-022-00601-z · DOI · Paper page
  2. 10.1038/s41570-019-0108-0 · DOI · Paper page
  3. 10.1038/nature05529 · DOI · Paper page
  4. 10.1016/S0092-8674(00)81023-5 · DOI
  5. 10.1016/j.cell.2017.05.015 · DOI · Paper page
  6. 10.1152/physrev.00020.2018 · DOI · Paper page
  7. 10.1016/j.canlet.2021.07.002 · DOI
  8. 10.1002/aac2.12067 · DOI
  9. 10.1016/j.tcb.2018.02.001 · DOI · Paper page
  10. 10.3390/ijms23084168 · DOI
  11. 10.1111/j.1474-9726.2006.00199.x · DOI · Paper page
  12. 10.1073/pnas.92.20.9363 · DOI · Paper page
  13. 10.3390/biom13020362 · DOI
  14. 10.1021/acs.bioconjchem.9b00391 · DOI
  15. 10.1039/D1SC02069B · DOI
  16. 10.1007/s00216-020-03111-8 · DOI
  17. 10.1016/j.enzmictec.2021.109885 · DOI
  18. 10.1039/D0QM00683A · DOI
  19. 10.1002/cbic.202200364 · DOI
  20. 10.1038/s41598-019-38511-z · DOI
  21. 10.1021/acs.jmedchem.1c01313 · DOI
  22. 10.1152/physrev.00049.2010 · DOI
  23. 10.1109/TMI.2004.824150 · DOI
  24. 10.1158/1538-7445.AM2019-1146 · DOI
  25. 10.1016/j.bbagen.2021.129898 · DOI
  26. 10.1007/s004240050843 · DOI
  27. 10.1146/annurev-pathol-121808-102144 · DOI · Paper page
  28. 10.1016/j.semcancer.2021.03.021 · DOI
  29. 10.1038/s41569-020-0431-7 · DOI
  30. 10.1038/s41574-020-0335-y · DOI · Paper page
  31. 10.1038/s41418-020-0564-6 · DOI
  32. 10.1093/nar/28.1.235 · DOI · Paper page
  33. 10.1021/bi011727i · DOI
  34. 2021, Schrödinger Release 2021-3: LigPrep
  35. 10.1007/s10822-007-9133-z · DOI
  36. 10.1021/jm0306430 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Xiang, X., Dong, C., Zhou, L., Liu, J., Rabinowitz, Z. M., Zhang, Y., Guo, H., He, F., Chen, X., Wang, Y., Cui, L., & Ma, X.
Venue
Journal of Medicinal Chemistry
Published
2024-03-20
Volume
67
Issue
7
Pages
5924-5934
ISSN
  • 0022-2623
  • 1520-4804
Cited by
41
References
10
Language
en
Funders
  • Fundamental Research Funds for Central Universities of the Central South University (2022ZZTS0856)
  • National Institute on Aging (R41AG081007)
  • Key Research and Development Program of Hunan Province of China (2022SK2035)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review